Padoporfin (WST11)

padoporfin · Steba Biotech S.A.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Padoporfin (WST11), covering 2015-04-28 to 2015-04-28. Get the full timeline:

Most recent: Clinical Trial Update: Study Using WST11 in Patients With Localized Prostate Cancer [Phase 2]